Higher IL-9 Level is Associated with Psoriasis Vulgaris Complicated by Metabolic Syndrome
Liang Yan,1,2 Chongli Yu,1 Zhenkai Zhao,1 Yuan Zhang,1 Rui Wang,1 Chengxin Li1 1Department of Dermatology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China; 2Department of Dermatology, General Hospital of Central Theater Command of PLA, Wuhan, Hubei...
Main Authors: | Yan L, Yu C, Zhao Z, Zhang Y, Wang R, Li C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/higher-il-9-level-is-associated-with-psoriasis-vulgaris-complicated-by-peer-reviewed-fulltext-article-CCID |
Similar Items
-
Imbalance between serum interleukin-36 and interleukin-38 is associated with metabolic syndrome in psoriasis vulgaris
by: Marwa A Amer, et al.
Published: (2023-01-01) -
Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
by: Makiko Yajima, et al.
Published: (2019-03-01) -
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
by: Hanley TL, et al.
Published: (2017-03-01) -
Assessment of tissue level of interleukin-9 in psoriasis and vitiligo
by: Sara B Mahmoud, et al.
Published: (2023-01-01) -
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
by: Rahim Farahani, et al.
Published: (2014-01-01)